Hypoglycemia News and Research

RSS
Hypoglycemia, also called low blood glucose or low blood sugar, occurs when blood glucose drops below normal levels. Glucose, an important source of energy for the body, comes from food. Carbohydrates are the main dietary source of glucose.
Intensive glucose control halves complications of longstanding type 1 diabetes

Intensive glucose control halves complications of longstanding type 1 diabetes

NDA for Exenatide once weekly accepted for FDA review

NDA for Exenatide once weekly accepted for FDA review

Novel diabetes treatment Syncria (albiglutide) improves glucose control and reduces weight

Novel diabetes treatment Syncria (albiglutide) improves glucose control and reduces weight

Researchers find early signs of diabetes in healthy children as young as seven

Researchers find early signs of diabetes in healthy children as young as seven

Comprehensive review on sulfonylureas in the latest issue of Diabetic Hypoglycemia

Comprehensive review on sulfonylureas in the latest issue of Diabetic Hypoglycemia

Glucose metabolism and recidivism of severe violent crimes in alcohol intoxications

Glucose metabolism and recidivism of severe violent crimes in alcohol intoxications

Glucose monitoring devices benefit people with type 1 diabetes

Glucose monitoring devices benefit people with type 1 diabetes

Hypoglycemia poses a serious health threat for patients with chronic kidney disease

Hypoglycemia poses a serious health threat for patients with chronic kidney disease

Severe hypoglycemia linked with higher risk of dementia for seniors with diabetes

Severe hypoglycemia linked with higher risk of dementia for seniors with diabetes

Hypoglycemic episodes increase dementia risk in seniors with type 2 diabetes

Hypoglycemic episodes increase dementia risk in seniors with type 2 diabetes

Research finds insulin plays a key role in suppressing levels of glucagon

Research finds insulin plays a key role in suppressing levels of glucagon

Dapagliflozin trial results indicate improvement in key glycemic measures in treatment-naive type 2 diabetes

Dapagliflozin trial results indicate improvement in key glycemic measures in treatment-naive type 2 diabetes

Trial looks at intensive insulin therapy risks

Trial looks at intensive insulin therapy risks

Study finds risks and benefits of intensive insulin therapy in neurosurgical patients

Study finds risks and benefits of intensive insulin therapy in neurosurgical patients

Comprehensive systematic review of insulin analogues

Comprehensive systematic review of insulin analogues

Amylin, Lilly update on FDA review of Byetta (exenatide) injection monotherapy submission

Amylin, Lilly update on FDA review of Byetta (exenatide) injection monotherapy submission

Fear of hypoglycemia a barrier to exercise for type 1 diabetics

Fear of hypoglycemia a barrier to exercise for type 1 diabetics

Halozyme Therapeutics starts phase 2 trial of insulin with rHuPH20 in type 1 diabetes

Halozyme Therapeutics starts phase 2 trial of insulin with rHuPH20 in type 1 diabetes

GlaxoSmithKline believes there is no liver safety issue with Avandia (rosiglitazone maleate)

GlaxoSmithKline believes there is no liver safety issue with Avandia (rosiglitazone maleate)

FDA continues review of Takeda's NDA for Alogliptin

FDA continues review of Takeda's NDA for Alogliptin

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.